Tumour heterogeneity
نویسندگان
چکیده
منابع مشابه
Quantifying tumour heterogeneity with CT
Heterogeneity is a key feature of malignancy associated with adverse tumour biology. Quantifying heterogeneity could provide a useful non-invasive imaging biomarker. Heterogeneity on computed tomography (CT) can be quantified using texture analysis which extracts spatial information from CT images (unenhanced, contrast-enhanced and derived images such as CT perfusion) that may not be perceptibl...
متن کاملPhylogenetic Quantification of Intra-tumour Heterogeneity
As sequencing efforts continue to reveal the extent of the intratumor heterogeneity (ITH) present in human cancers, the importance of evolutionary studies attempting to trace its etiology has increased. Sequencing multiple samples or tumor regions from the same patient has become affordable and is an effective way of tracing these evolutionary pathways, understanding selection, and detecting cl...
متن کاملImproving tumour ADC estimates and elucidating tumour heterogeneity using adaptive Bayesian Markov random field Monte Carlo
Figure 2: Simulated (left) and in vivo (right) ADC point estimates without adaptive smoothing (a and e) and with adaptive smoothing (b and f). ADC uncertainties with adaptive smoothing (c and g) and without adaptive smoothing (d and h). On all maps with adaptive smoothing, the borrowing strength is shown by a border around each pixel; bright lines indicate strong borrowing; dark lines indicate ...
متن کاملDoes heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
BACKGROUND Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study was to compare stereology with semi-quantitative estimations of TSR, to investigate the intra-tumoural hete...
متن کاملProfiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
The majority of pancreatic ductal adenocarcinomas (PDAC) are diagnosed late so that surgery is rarely curative. Earlier detection could significantly increase the likelihood of successful treatment and improve survival. The aim of the study was to provide proof of principle that point mutations in key cancer genes can be identified by sequencing circulating free DNA (cfDNA) and that this could ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 2013
ISSN: 0028-0836,1476-4687
DOI: 10.1038/501327a